4′-Methyl-4,5′-bithiazole-based correctors of defective ΔF508-CFTR cellular processing
- 15 April 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (8), 2610-2614
- https://doi.org/10.1016/j.bmcl.2008.03.037
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Small-molecule correctors of defective F508-CFTR cellular processing identified by high-throughput screeningJournal of Clinical Investigation, 2005
- Phenylglycine and Sulfonamide Correctors of Defective ΔF508 and G551D Cystic Fibrosis Transmembrane Conductance Regulator Chloride-Channel GatingMolecular Pharmacology, 2005
- Nanomolar Affinity Small Molecule Correctors of Defective ΔF508-CFTR Chloride Channel GatingJournal of Biological Chemistry, 2003
- Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin–induced intestinal fluid secretionJournal of Clinical Investigation, 2002
- Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin–induced intestinal fluid secretionJournal of Clinical Investigation, 2002
- Cystic fibrosis: A worldwide analysis ofCFTR mutations?correlation with incidence data and application to screeningHuman Mutation, 2002
- Green fluorescent protein‐based halide indicators with improved chloride and iodide affinitiesFEBS Letters, 2001
- Cooh-Terminal Truncations Promote Proteasome-Dependent Degradation of Mature Cystic Fibrosis Transmembrane Conductance Regulator from Post-Golgi CompartmentsThe Journal of cell biology, 2001
- Molecular pharmacology of the CFTR Cl− channelTrends in Pharmacological Sciences, 1999
- Chloride Conductance Expressed by ΔF508 and Other Mutant CFTRs In Xenopus OocytesScience, 1991